Award
National Cancer Institute 5U2CCA271903-04
Biomarker Developmental Laboratory
Recipient
Not specified
Award Amount
$263,058.00
Ceiling
$263,058.00
Awarded
September 09, 2025
Identifier
5U2CCA271903-04
Award for developing biochemical biomarkers for lung and ovarian cancer screening to improve early detection and reduce false positives, involving advanced proteomics technologies and multi-center collaborations.
Description
The project focuses on developing circulating biochemical biomarkers for lung and ovarian cancer screening using technologies such as high-throughput immunoproteomics, protein arrays, and validation assays. It involves collaborations with multiple research centers and aims to improve early detection and reduce false positives in cancer screening.